The ODG return to work guidelines, offered as an integrated package with the ODG treatment guidelines, are designed for prospective case/claims management as well as retrospective benchmarking.
What is SUBSYS? SUBSYS is a prescription medicine that contains the medicine fentanyl. SUBSYS is used to manage breakthrough pain in adults with cancer, who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. SUBSYS is started only after you have been taking other opioid pain
November 30, 2017 -- The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated treatment with a transmucosal (absorbed through mucus membrane) buprenorphine-containing product.